Merck KGaA

Merck KGaA specializes in producing reagents and mounting media primarily used in light microscopy. This includes staining solutions like May-Grünwald’s eosine-methylene blue, hematoxylin (modified Gill III), and eosin Y, as well as mounting agents such as Canada balsam, Entellan™, and immersion oil. The company also offers buffer tablets for preparing staining solutions and reference slides for detecting acid-fast bacteria in tissue samples.

Merck KGaA is based in Germany, which places its devices under the jurisdiction of the European Union’s Medical Device Regulations (MDR). Since the company’s products are designed for use within the EU market, they must comply with MDR requirements, including registration in the EUDAMED database. The classification of these devices as Class A or Class B determines the specific regulatory obligations, such as risk management and technical documentation.

Yes, Merck KGaA’s devices are listed in the eudamed database, which is the official EU registry for medical devices. This listing ensures transparency and traceability, allowing healthcare professionals, regulators, and authorities to verify the manufacturer’s details and device information. Listing in eudamed is a requirement under EU MDR for devices placed on the market, helping to maintain compliance and facilitate market surveillance.

Merck KGaA’s devices are classified as Class A (low-risk, non-invasive diagnostic reagents) or Class B (moderate-risk, invasive or measuring body functions) under EU MDR. Classification determines the regulatory scrutiny and documentation requirements: Class A devices typically require less stringent post-market surveillance than Class B, which may involve additional risk management measures. The classification is based on factors like intended use, duration of contact with the body, and potential risks.